PROXY STATEMENT

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

May 7, 2025

Period of Report

May 29, 2025

Accession Number

0001213900-25-040263

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →